Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Berry Consultants specializes in the design, analysis, implementation, and simulation of innovative adaptive clinical trials using Bayesian methods. Their work enables more efficient drug/device development by optimizing trial structure and decision-making. They have contributed to landmark studies such as seamless phase II/III trials for GLP‑1 agonists like dulaglutide ("Trulicity") and major platform trials in oncology. They do not sponsor or own their own pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Berry Consultants.